Takashi Osaki

603 total citations
28 papers, 474 citations indexed

About

Takashi Osaki is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Takashi Osaki has authored 28 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 4 papers in Organic Chemistry. Recurrent topics in Takashi Osaki's work include Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Takashi Osaki is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Takashi Osaki collaborates with scholars based in Japan, Vietnam and United States. Takashi Osaki's co-authors include Hirokazu Hara, Noriyuki Furuichi, Shigeo Katsumura, Hajime Mori, Noboru Tanaka, Kiyomi Suzuka, Masayuki Nakano, K. Kato, Kyoichi Kaira and Hisao Imai and has published in prestigious journals such as Angewandte Chemie International Edition, Cancer Research and The Journal of Organic Chemistry.

In The Last Decade

Takashi Osaki

26 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takashi Osaki Japan 10 219 112 111 72 60 28 474
Maurie Markman United States 8 123 0.6× 134 1.2× 161 1.5× 35 0.5× 107 1.8× 12 434
Evelien Smitskamp-Wilms Netherlands 9 86 0.4× 114 1.0× 207 1.9× 49 0.7× 35 0.6× 13 370
Simona Romanelli Italy 5 76 0.3× 198 1.8× 194 1.7× 25 0.3× 24 0.4× 6 368
Chul‐Hoon Kwon United States 17 338 1.5× 54 0.5× 216 1.9× 27 0.4× 299 5.0× 53 925
Christine Williamson United Kingdom 14 55 0.3× 186 1.7× 210 1.9× 41 0.6× 20 0.3× 24 443
Mina Razzak United Kingdom 9 171 0.8× 63 0.6× 129 1.2× 52 0.7× 34 0.6× 49 397
U. Holwerda Netherlands 10 33 0.2× 216 1.9× 254 2.3× 79 1.1× 42 0.7× 13 572
Ulrike Olszewski Austria 14 161 0.7× 326 2.9× 171 1.5× 31 0.4× 41 0.7× 20 506
Toshiyuki Seki Japan 12 123 0.6× 77 0.7× 102 0.9× 12 0.2× 24 0.4× 34 386

Countries citing papers authored by Takashi Osaki

Since Specialization
Citations

This map shows the geographic impact of Takashi Osaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Osaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Osaki more than expected).

Fields of papers citing papers by Takashi Osaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Osaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Osaki. The network helps show where Takashi Osaki may publish in the future.

Co-authorship network of co-authors of Takashi Osaki

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Osaki. A scholar is included among the top collaborators of Takashi Osaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Osaki. Takashi Osaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koga, Yasuhiko, Mitsuru Motegi, Akihiro Ono, et al.. (2025). Serum galectin-3 as a biomarker of progression of idiopathic pulmonary fibrosis treated with nintedanib. Respiratory Investigation. 63(3). 394–398. 1 indexed citations
2.
3.
4.
Yamaguchi, Ou, Hisao Imai, Hiroyuki Minemura, et al.. (2020). Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 85(4). 761–771. 39 indexed citations
5.
Imai, Hisao, Yoshio Tomizawa, Kyoichi Kaira, et al.. (2020). Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer. Chemotherapy. 65(1-2). 21–28. 3 indexed citations
6.
Imai, Hisao, Ou Yamaguchi, Kensuke Suzuki, et al.. (2019). P1.04-34 Efficacy and Safety of First-Line Pembrolizumab Monotherapy in Elderly Patients (Aged ≥ 75 years) with Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S453–S453.
7.
Imai, Hisao, Ou Yamaguchi, Kensuke Suzuki, et al.. (2019). Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 146(2). 457–466. 22 indexed citations
8.
Kaira, Kyoichi, Osamu Kawashima, Kazuyoshi Imaizumi, et al.. (2018). Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma. Human Pathology. 84. 142–149. 32 indexed citations
9.
Tokunaga, Jin, Norito Takamura, Kenji Ogata, et al.. (2014). An Advanced Objective Structured Clinical Examination Using Patient Simulators to Evaluate Pharmacy Students’ Skills in Physical Assessment. American Journal of Pharmaceutical Education. 78(10). 184–184. 7 indexed citations
10.
Tokunaga, Jin, Norito Takamura, Kenji Ogata, et al.. (2013). Skills Evaluation about Physical Assessment by New Advanced OSCE Using the Patient Simulator and related Problems. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 39(4). 208–219. 1 indexed citations
11.
Hirano, Tomoya, Takashi Osaki, Shinya Fujii, et al.. (2008). Fluorescent visualization of the conformational change of aromatic amide or urea induced by N-methylation. Tetrahedron Letters. 50(4). 488–491. 12 indexed citations
12.
Kato, K., Kiyomi Suzuka, Takashi Osaki, & Noboru Tanaka. (2007). Unilateral or bilateral nerve-sparing radical hysterectomy: a surgical technique to preserve the pelvic autonomic nerves while increasing radicality. International Journal of Gynecological Cancer. 17(5). 1172–1178. 35 indexed citations
13.
Osaki, Takashi, et al.. (2007). Novel Water-Soluble Sedative-Hypnotic Agents: Isoindolin-1-one Derivatives. Chemical and Pharmaceutical Bulletin. 55(12). 1682–1688. 109 indexed citations
14.
Kato, Kazuki, Kiyomi Suzuka, Takashi Osaki, Makiko Itami, & Noboru Tanaka. (2007). Primary hepatoid adenocarcinoma of the uterine cervix. International Journal of Gynecological Cancer. 17(5). 1150–1154. 20 indexed citations
15.
Osaki, Takashi, et al.. (2005). A Case of Desmoid Tumor in the Posterior Neck. Practica Oto-Rhino-Laryngologica. 98(1). 67–74. 1 indexed citations
16.
Osaki, Takashi, et al.. (2004). Inflammatory Pseudotumor of the Parapharyngeal Space. Practica Oto-Rhino-Laryngologica. 97(6). 537–542. 2 indexed citations
17.
Osaki, Takashi, et al.. (2003). Parotid Tumors; Clinical Study of 36 Cases. Practica Oto-Rhino-Laryngologica. 96(9). 799–804. 4 indexed citations
18.
Furuichi, Noriyuki, Hirokazu Hara, Takashi Osaki, Hajime Mori, & Shigeo Katsumura. (2002). Highly Efficient Stereocontrolled Total Synthesis of the Polyfunctional Carotenoid Peridinin. Angewandte Chemie International Edition. 41(6). 1023–1026. 61 indexed citations
19.
Kohdera, Urara, et al.. (1998). Cystic neuroblastoma identified by prenatal ultrasonography. Pediatric Radiology. 28(3). 198–198. 3 indexed citations
20.
Kano, Noriaki, et al.. (1992). The cytologic study on the endocervical glandular dysplasia and related lesions in the uterine cervix.. The Journal of the Japanese Society of Clinical Cytology. 31(6). 943–949.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maurie Markman Breakdown of academic impact, for papers by Evelien Smitskamp-Wilms Breakdown of academic impact, for papers by Simona Romanelli Breakdown of academic impact, for papers by Chul‐Hoon Kwon Breakdown of academic impact, for papers by Christine Williamson Breakdown of academic impact, for papers by Mina Razzak Breakdown of academic impact, for papers by U. Holwerda Breakdown of academic impact, for papers by Ulrike Olszewski Breakdown of academic impact, for papers by Toshiyuki Seki
Rankless by CCL
2026